Patient Guide: A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 17 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05955508
Status: 🟢 Enrolling Now
Condition: Smoldering Multiple Myeloma (SMM)
Phase: PHASE2

Where You Can Participate

This study is available at 17 locations across the country.

Top locations include:
  • • Santiago de Compostela, A Coruna
  • • Granada, Andalusia
  • • Palma Mallorca, Balearic Islands
  • • And 14 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma - Join Clinical Trial NCTNCT05955508

How to Join This Clinical Trial - NCTNCT05955508

Learn how to participate in this PHASE2 trial studying an investigational therapy for Smoldering Multiple Myeloma (SMM). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Smoldering Multiple Myeloma (SMM). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Smoldering Multiple Myeloma (SMM)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05955508 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 17 locations. Find a study site near you:

Clinical Research Site

Santiago de Compostela, A Coruna 15706 - Spain

Status: RECRUITING

Clinical Research Site

Granada, Andalusia 18014 - Spain

Status: RECRUITING

Clinical Research Site

Palma Mallorca, Balearic Islands 07198 - Spain

Status: RECRUITING

Clinical Research Site

Badalona, Barcelona 08916 - Spain

Status: RECRUITING

Clinical Research Site

Santander, Cantabria 39008 - Spain

Status: RECRUITING

Clinical Research Site

Pozuelo de Alarcón, Madrid 28223 - Spain

Status: RECRUITING

Clinical Research Site

El Palmar, Murcia 30120 - Spain

Status: RECRUITING

Clinical Research Site

Pamplona, Navarre 31008 - Spain

Status: RECRUITING

Clinical Research Site

Gijón, Principality of Asturias 33203 - Spain

Status: RECRUITING

Clinical Research Site

Barcelona, 08036 - Spain

Status: RECRUITING

And 7 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Smoldering Multiple Myeloma (SMM):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships